Harbor Capital Advisors Inc. lowered its position in shares of MKS Instruments, Inc. (NASDAQ:MKSI - Free Report) by 5.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 109,755 shares of the scientific and technical instruments company's stock after selling 5,752 shares during the quarter. Harbor Capital Advisors Inc. owned approximately 0.16% of MKS Instruments worth $8,797,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Steward Partners Investment Advisory LLC boosted its holdings in shares of MKS Instruments by 68.6% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 263 shares of the scientific and technical instruments company's stock worth $27,000 after purchasing an additional 107 shares during the last quarter. TD Private Client Wealth LLC acquired a new stake in MKS Instruments in the 4th quarter worth about $39,000. Blue Trust Inc. grew its holdings in MKS Instruments by 424.1% in the 4th quarter. Blue Trust Inc. now owns 414 shares of the scientific and technical instruments company's stock valued at $45,000 after buying an additional 335 shares during the period. Harvest Fund Management Co. Ltd increased its stake in shares of MKS Instruments by 24,900.0% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 500 shares of the scientific and technical instruments company's stock valued at $52,000 after acquiring an additional 498 shares during the last quarter. Finally, Parallel Advisors LLC lifted its holdings in shares of MKS Instruments by 89.3% during the 1st quarter. Parallel Advisors LLC now owns 581 shares of the scientific and technical instruments company's stock worth $47,000 after acquiring an additional 274 shares during the period. 99.79% of the stock is owned by hedge funds and other institutional investors.
MKS Instruments Stock Down 2.4%
Shares of MKSI stock traded down $2.28 on Friday, hitting $91.47. The stock had a trading volume of 211,600 shares, compared to its average volume of 1,049,030. The firm has a market capitalization of $6.17 billion, a price-to-earnings ratio of 32.60, a P/E/G ratio of 1.02 and a beta of 1.84. The stock's 50 day moving average is $78.45 and its 200-day moving average is $94.06. The company has a debt-to-equity ratio of 1.93, a quick ratio of 2.04 and a current ratio of 3.19. MKS Instruments, Inc. has a 52-week low of $54.84 and a 52-week high of $147.40.
MKS Instruments (NASDAQ:MKSI - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The scientific and technical instruments company reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.29. MKS Instruments had a net margin of 5.30% and a return on equity of 18.94%. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $913.59 million. During the same period in the prior year, the company posted $1.18 EPS. The firm's revenue for the quarter was up 7.8% on a year-over-year basis. As a group, research analysts expect that MKS Instruments, Inc. will post 6.94 earnings per share for the current year.
MKS Instruments Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, June 6th. Stockholders of record on Tuesday, May 27th were paid a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend was Tuesday, May 27th. MKS Instruments's dividend payout ratio (DPR) is currently 26.27%.
Wall Street Analysts Forecast Growth
MKSI has been the subject of several research analyst reports. Morgan Stanley upped their price target on shares of MKS Instruments from $93.00 to $100.00 and gave the stock an "overweight" rating in a research report on Friday, May 23rd. The Goldman Sachs Group lifted their target price on MKS Instruments from $128.00 to $129.00 and gave the company a "neutral" rating in a report on Friday, February 14th. Needham & Company LLC dropped their price target on MKS Instruments from $145.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Cantor Fitzgerald restated an "overweight" rating and issued a $140.00 price objective on shares of MKS Instruments in a report on Thursday, February 13th. Finally, Benchmark decreased their target price on MKS Instruments from $142.00 to $135.00 and set a "buy" rating for the company in a report on Friday, February 14th. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $132.64.
Get Our Latest Stock Report on MKSI
MKS Instruments Company Profile
(
Free Report)
MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.
Further Reading

Before you consider MKS Instruments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MKS Instruments wasn't on the list.
While MKS Instruments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.